Seyfried, Timo

Seyfried, Timo

Biography

Timo Fabian Seyfried, MD, PhD

20.04.1983 born in Pforzheim, Germany
2003-09           Medical Studies, University Regensburg
2009- current   Dept. of  Anaesthesiology, University of Regensburg (Prof. B.M. Graf, MSc.)
06/2015           Specialist Anaesthesiology
07/2016           Specialist Pain medicine
11/2019           Specialist Intensive care

Current position: starting 01/2021 head of the department orthopaedic and neurosurgery, Ernst von Bergmann Klinikum Potsdam, Germany
Since 2013 head of the cell salvage research group
from 2017-2020 Patient Blood Management coordinator University Hospital Regensburg
12/2018 habilitation(PhD), appointment to private lecturer, University of Regensburg 
 

Research Interests:

Emergency medicine   
BIS as a prognostic parameter after CPR
Management of in-hospital CP

Transfusion Medicine 
Cell salvage
Blood Salvage with Blood Irradiation in Cancer Surgery
Patient Blood Management

Publications:

Hansen E, Seyfried T. [Cell Salvage] Maschinelle Autotransfusion. Anaesthesist 2011; 60:381-390

Gruber M, Breu A, Frauendorf M, Seyfried T, Hansen E. Washing of banked blood by three different blood salvage devices. Transfusion 2013; 53(5):1001-1009

Seyfried T, Breu A, Gruber M, Reipert J, Hansen E. Processing of small volumes in blood salvage devices. Transfusion 2014; 54:2775-2781

Seyfried TF, Haas L; Gruber M, Breu A, Loibl M, Hansen E. Fat removal during cell salvage- A comparison of four different cell salvage devices. Transfusion 2015; 55(7):1637-1643

Seyfried TF, Haas L; Gruber M, Breu A, Loibl M, Hansen E. Fat removal during cell salvage: an optimized program for a discontinuous autotransfusion device. Transfusion 2015

Seyfried TF, Gruber M, Pawlik MT, Kasper S, Mandle RJ, Hansen E. A new approach for fat removal in a discontinuous autotransfusion device-concept and evaluation.Vox Sang. 2017 Nov;112(8):759-766.

Seyfried, TF; Michael Gruber; Diane Bitzinger; Michael T. Pawlik; Anita Breu; Bernhard M. Graf; Ernil Hansen. Performance of a new generation continuous autotransfusion device including fat removal and consequences for quality controls. Transfus Med. 2017 Aug;27(4):292-299. doi: 10.1111/tme.12421

Seyfried TF, Gruber M., Streithoff F., Mandle RJ, Michael Pawlik MT,Busse H., and Hansen E. The impact of bowl size, program setup and blood hematocrit on performance of a discontinuous autotransfusion system. Transfusion. 2017 Mar;57(3):589-598.

Seyfried TF, Streithoff F, Gruber M, Unterbuchner C, Zech N, Kieninger M, Hansen E. Platelet sequestration with a new-generation autotransfusion device. Transfusion. 2018 Jan 30

Seyfried TF, Hansen E.Cell salvage : Scientific evidence, clinical practice and legal framework. Anaesthesist. 2019 Feb;68(2):69-82

All sessions by Seyfried, Timo

Cell salvage in cancer surgery – a no go?

14 Apr 2021
09:30 - 09:45 CEST

Cell salvage in cancer surgery – a no go?

16 Apr 2021
17:30 - 17:45 CEST